Cited by 62Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityDiabetes, Cardiovascular Risks, and Lipoproteins

Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study

Patel, Dharmendrakumar A., Srinivasan, Sathanur R., Xu, Ji-Hua, Chen, Wei, Berenson, Gerald S.·2006·Metabolism

Abstract

Adiponectin, a novel adipocytokine produced exclusively in the adipose tissue, plays a major role in the development of metabolic syndrome, type 2 diabetes mellitus, and related cardiovascular (CV) diseases. However, information is scant regarding the association of adiponectin with measures of CV risk in young adults. This aspect was examined in a biracial (black-white) community-based sample of 1153 individuals (mean age, 36.2 years; 70% white, 43% male) who participated in the Bogalusa Heart Study. Adiponectin levels showed race (white > black, P < .0001) and sex (female > male, P < .0001) differences, and correlated significantly in a beneficial manner to measures of obesity (body mass index, waist circumference, and abdominal height), mean arterial blood pressure, lipoprotein variables (low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), measures of glucose homeostasis (insulin, glucose, homeostasis model assessment of insulin resistance [HOMA-IR]), and uric acid, after adjusting for age, race, sex, and cigarette smoking. In multivariate analysis that used either body mass index or abdominal height as a measure of general and visceral adiposity in 2 separate models, HOMA-IR was the major contributor explaining 18.4% and 18.1% of the variance, respectively. There was a significant interaction between abdominal height and HOMA-IR on adiponectin level in that the inverse association between adiponectin and insulin resistance was pronounced at higher level of visceral adiposity. Furthermore, adiponectin levels decreased with increasing number of metabolic syndrome risk factors defined by the National Cholesterol Education Program Adult Treatment Panel III (P for trend <.0001). Moreover, adiponectin levels were low among those with positive parental histories of coronary heart disease (P = .03), hypertension (P = .04), and type 2 diabetes mellitus (P = .01), considered as surrogate measures of risk. These findings, by showing an inverse association of adiponectin with insulin resistance, visceral adiposity, and related metabolic syndrome, and also with positive parental histories of coronary heart disease, hypertension, and type 2 diabetes mellitus, underscore the value of adiponectin in CV and type 2 diabetes mellitus risk assessments in young adults.

Integrity signals

Registry

Crossref · 10.1016/j.metabol.2006.06.028

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical studies have established correlations between plasma adiponectin levels and various aspects and severity of heart failure.

    “First, an important pathophysiological contribution was suggested by the recent explosion in the number of clinical studies that have established correlations between plasma adiponectin levels and various aspects and severity of heart failure (107, 113, 143, 166, 172, 183, 198, 209, 251, 275, 282, 286, 303, 312, 366).”

    From Cardiac remodeling in obesity (2008) · cites this paper as [275]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Patel, D. A., Srinivasan, S. R., Xu, J.-H., Chen, W., & Berenson, G. S.
Affiliations
Tulane University (US)
Corresponding author
Berenson, Gerald S.
Venue
Metabolism
Publisher
Elsevier BV
Published
2006-11
Volume
55
Issue
11
Pages
1551-1557
ISSN
0026-0495 (ISSN-L)
OpenAlex
W1989310165
Cited by
62
References
45
Citations by year
2024: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2015: 2 · 2014: 1 · 2013: 6 · 2012: 7
FWCI
5.39
Type
journal article
Language
en
Open access
closed
Locations
  • Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (AG16592, R01AG016592)
  • National Heart, Lung, and Blood Institute (HL 38 844)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
adiponectin, cardiovascular risk, young adults, insulin resistance, visceral fat, metabolic syndrome, type 2 diabetes, coronary artery disease, hypertension, racial differences, sex differences, Bogalusa Heart Study
MeSH terms
Adult, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Female, Humans, Insulin, Insulin Resistance, Lipoproteins, Male, Sex Factors, Uric Acid, Cohort Studies, Body Mass Index, Linear Models, Metabolic Syndrome, Adiposity, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review